MedTrace Logo

BIOTRONIK 4French for AMBulatory Peripheral Intervention

NCT03044002 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 821

Last updated 2021-04-01

No results posted yet for this study

Summary

BIOTRONIK 4French for AMBulatory peripheral intervention. A multicenter, controlled trial comparing 4French versus 6French femoral access for endovascular treatment of lower-extremity peripheral artery disease in an ambulatory setting: BIO4AMB

Conditions

Interventions

DEVICE

Biotronik 4 French Portfolio

Ambulatory intervention by femoral access for endovascular treatment of lower-extremity peripheral artery disease

DEVICE

6 French Portfolio

Ambulatory intervention by femoral access for endovascular treatment of lower-extremity peripheral artery disease

Sponsors & Collaborators

  • Biotronik AG

    lead INDUSTRY

Principal Investigators

  • PD Dott. med. Jos van den Berg · Ospedale Regionale di Lugano - Sezione Civico

  • a.o. Univ. Prof. Dr. Marianne Brodmann · Substitute Head of the Clinical Division of Angiology, Department of Internal Medicine

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-17
Primary Completion
2020-10-20
Completion
2020-10-20

Countries

  • Austria
  • Belgium
  • France
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03044002 on ClinicalTrials.gov